Burzynski Michele MD is categorized under Internal Medicine Doctors in Arlington, TX and active since 1971.
Burzynski Michele MD was established in 1971, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michele Burzynski at the company’s single location by writing to 950 North Davis Drive # 2, Arlington, Texas TX 76012 or by phoning (817) 277-4723. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Burzynski Michele MD |
Contact Person: | Michele Burzynski |
Address: | 950 North Davis Drive # 2, Arlington, Texas 76012 |
Phone Number: | (817) 277-4723 |
Website Address: | arlingtonphysicians.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1971 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Burzynski Michele MD was started in 1971 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michele Burzynski for inquiries that concern Burzynski Michele MD by calling the company number (817) 277-4723, as your correspondence is most welcome. Additionally, the physical location of the single location of Burzynski Michele MD can be found at the coordinates 32.74776,-97.12303 as well as the street address 950 North Davis Drive # 2 in Arlington, Texas 76012.
For its online presence, you may visit Burzynski Michele MD’s website at arlingtonphysicians.com and engage with its social media outlets through on Twitter and on Facebook.